Previous 10 | Next 10 |
Generex Now Owns 99% of Subsidiary Olaregen Therapeutix Generex Satisfies Notes for $138,000 and $900,000 to clear debt NuGenerex Immuno-Oncology Spin-out Evaluating Acquisition of a Hospital Network Completed Audit of Direct-to-Patient Pharmacy Business MIRAMAR, Fla., Aug. 1...
Generex Biotechnology ( OTCQB:GNBT -7.3% ) announces that it has identified (but does not disclose) a public development-stage company that will serve as the vehicle (appears to be a reverse merger) for the spinout of subsidiary NuGenerex Immuno-Oncology (NGIO) as a standalone organizati...
Filing of up-list application to Nasdaq Record date for dividend is August 30, 2019 Pay date for 1:1 shareholder stock dividend set for October 29, 2019 Ex-dividend date for 1:1 shareholder stock dividend set for October 30, 2019 Effect of Dividend on GNBT Shares Outstanding -- Retirin...
• Filing of up-list application to Nasdaq • Record date for dividend is August 30, 2019 • Pay date for 1:1 shareholder stock dividend set for October 29, 2019 • Ex-dividend date for 1:1 shareholder stock dividend set for October 30,...
Filing of up-list application to Nasdaq New Dates Established for 1:1 Shareholder stock dividend New Record Date: August 30, 2019 Pay Date: October 30, 2019 Ex-Date: October 31, 2019 Dividend to be Paid to show Appreciation to our Shareholders MIRAMAR, Fla., Aug. 12, 2019 (GLO...
MIRAMAR, Fla., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) (“Generex”) today provided a news alert for GNBT shareholders that the Company will make an announcement on Monday August 12, 2019 at 8 AM pertaining to the paym...
MIRAMAR, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB:GNBT) today announced that Joe Moscato, the company’s President & Chief Executive Officer conducted an interview with the Wall Street Analyzer, which is available at: https://wallstreetana...
MediSource Partners Fresh Approach to Healthcare Network of healthcare providers, facilities, suppliers, and distributors Value Analysis Consulting Group Purchasing Distributorship (GPD) https://medisourcepartners.com MIRAMAR, Fla., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Generex Biotech...
Pantheon Medical Line of Orthopedic Implants “All-in-One” Foot & Ankle Kits https://pantheonortho.com MIRAMAR, Fla., July 31, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) is proud to introduce Pantheon Medical (https://...
Filing of up-list application to Nasdaq Details on 1:1 Shareholder stock dividend Recording and transcript of shareholders conference call available at www.generex.com MIRAMAR, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ...
News, Short Squeeze, Breakout and More Instantly...
Generex Biotechnology Company Name:
GNBT Stock Symbol:
OTCMKTS Market:
Generex Biotechnology Website:
MIRAMAR, Fla., July 26, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) subsidiary Olaregen Therapeutix announced in May that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc. (“Nexgen”) to be Ge...
Ii-Key Immunotherapeutic Vaccine Technology Ii-Key-SARS-CoV-2 Vaccine Market Potential & International Contracts Market Potential for AE37 (Ii-Key-HER2) Immunotherapeutic Vaccine for breast, prostate, and bladder cancers MIRAMAR, Fla., June 22, 2021 (GLOBE NEWSWIRE) --...
NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population. Westside Medicine & Cardiology, Inc. is a professional corporation that engages medical providers who are duly licensed in Ohio ...